EconomyBig Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Western biopharma companies are increasingly looking to China for drug innovation as the industry’s feared patent cliff approaches, driving deals worth billions of dollars.
C
CNBC★★☆☆☆2026-10-02 11:18Original
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Economy